Israel A, Gat R, Oster H, Moshe Y, Raz I, Mittelman M, Merzon E. Diabetes mellitus and diabetes-related complications are common in patients with myelodysplastic syndromes but Hemoglobin A1C is an inadequate marker. Haematologica 2026; 111(7):2504-2507; https://doi.org/10.3324/haematol.2025.300022.